Internal Medicine, Endocrinology, Diabetes, & Metabolism · Lititz, PA
NPI
1215934609
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1575 Highlands Dr, Suite 206
Lititz, PA, 17543
Phone (717) 568-8886
Groups this clinician bills Medicare through
Medicare paid, 2024
$88K
1,235 services
Medicare patients, 2024
354
Average age 73
Drug cost, 2024
$2.8M
6,538 prescriptions
Company payments, 2025
$1,568
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tipu Faiz M Saleem was code 99214 (office e&m - established), 659 times for 289 patients. In total Tipu Faiz M Saleem billed 1,235 services in 15 codes, and Medicare paid $88K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 659 | 289 | $85.55 | $56K |
| 95251 Test - Miscellaneous | Office | 282 | 100 | $25.40 | $7,162 |
| 99232 Hospital E&M - Subsequent | Facility | 99 | 30 | $60.31 | $5,971 |
| 99215 Office E&M - Established | Office | 39 | 26 | $130.79 | $5,101 |
| 99223 Hospital E&M - Initial | Facility | 32 | 31 | $132.34 | $4,235 |
| 99213 Office E&M - Established | Office | 29 | 26 | $43.27 | $1,255 |
| 99204 Office E&M - New | Office | 19 | 19 | $117.03 | $2,224 |
| 99441 Telephone Services | Office | 18 | 15 | $42.85 | $771 |
| 99205 Office E&M - New | Office | 18 | 18 | $155.31 | $2,795 |
| 95249 Test - Miscellaneous | Office | 16 | 16 | $48.12 | $770 |
| 76536 Ultrasound - Nonspecific | Office | 13 | 13 | $69.41 | $902 |
By year: 2022 $109K for 1,429 services; 2023 $96K for 1,326 services; 2024 $88K for 1,235 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tipu Faiz M Saleem prescribed most often to Medicare patients was Levothyroxine Sodium, with 614 prescriptions and refills. In total Tipu Faiz M Saleem wrote 6,538 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 614 | 1,586 | 153 | $5,733 |
| Metformin Hcl Generic | 441 | 1,068 | 119 | $3,248 |
| Farxiga Dapagliflozin Propanediol | 325 | 543 | 64 | $304K |
| Mounjaro Tirzepatide | 305 | 378 | 64 | $387K |
| Jardiance Empagliflozin | 266 | 432 | 52 | $246K |
| Ozempic Semaglutide | 245 | 352 | 52 | $332K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 218 | 552 | 81 | $23K |
| Novolog Flexpen Insulin Aspart | 215 | 383 | 73 | $66K |
| Trulicity Dulaglutide | 186 | 296 | 50 | $282K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 177 | 310 | 53 | $28K |
| Metformin Hcl Er Metformin Hcl | 176 | 439 | 59 | $1,313 |
| Atorvastatin Calcium Generic | 141 | 327 | 38 | $1,224 |
| Glipizide Generic | 129 | 328 | 40 | $675 |
| Methimazole Generic | 124 | 306 | 37 | $1,225 |
| Lisinopril Generic | 117 | 259 | 30 | $845 |
Brand drugs: 2,970 claims; generic drugs: 3,109 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tipu Faiz M Saleem $1,568 ($1,568 in general payments such as food, travel and fees) from 22 companies. The largest payer was Amgen Inc. with $375.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 20 | $375 |
| Lilly USA, LLC LLY | 9 | $175 |
| Novo Nordisk Inc NVO | 8 | $145 |
| Beta Bionics, Inc. BBNX | 2 | $127 |
| Mannkind Corporation MNKD | 5 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $67.86 |
| Amneal Pharmaceuticals LLC AMRX | 3 | $67.49 |
| Madrigal Pharmaceuticals MDGL | 2 | $67.19 |
| Acella Pharmaceuticals, LLC | 3 | $52.07 |
| Corcept Therapeutics CORT | 3 | $49.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.